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Ureteral obstruction decreases renal prepro-epidermal growth
factor and Tamm-Horsfall expression
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Ureteral obstruction decreases renal prepro-EGF and Tamm-Horsfall
expression. Northern and dot-blot analysis of polyadenylated RNAs of
kidney cortical and outer medullary tissue was performed in male
Sprague-Dawley rats at varying times up to 24 hours after bilateral
ureteral obstruction (BUO), after 24 hours of unilateral obstruction
(UUO) and at varying periods after release of BUO or UUO. Pre-
proEGF (preproEGF) and Tamm-Horsfall (TH) mRNA declined by
four hours of BUO to virtually undetectable levels at 24 hours of
ureteral obstruction. Upon release of BUO or UUO, preproEGF and
TH mRNA returned slowly toward normal but remained below control
levels up to four days after release of ureteral obstruction. Urinary EGF
excretion paralleled these changes in renal preproEGF mRNA. Al-
though these changes are similar to those observed during nephrotoxic
and ischemic renal failure, where the expression of the immediate early
genes precedes the fall in preproEGF and TH expression, no such
increase in the expression of these genes occurred after bilateral
ureteral obstruction. These changes in preproEGF and TH expression
could also be dissociated from uremia and high rates of DNA synthesis,
suggesting that ureteral obstruction itself is a sufficient cause of the
reduced expression. The increase in ureteral pressure and its functional
and humoral effects may each play a role in reduced preproEGF and TH
expression during ureteral obstruction.
has been studied only in models of acute renal failure associated
with prominent degrees of cell necrosis and active rates of DNA
synthesis. Thus the repression of these two genes may be linked
to the commitment to cell division. To determine whether
reduced renal preproEGF and Tamm-Horsfall expression could
be dissociated from high rates of renal DNA synthesis we
performed experiments in rats in which acute renal failure was
induced by complete ureteral obstruction. Renal cell necrosis,
enhanced DNA synthesis and regeneration are not prominent in
this model of acute renal failure [61. The results show that
ureteral obstruction reduces preproEGF and TH gene expres-
sion coordinately without elevated immediate early gene tran-
scription, cell necrosis or high rates of DNA synthesis. Ob-
struction itself is responsible for these changes in gene
expression.
Methods
Animal preparation
Recovery from acute renal failure is associated with in-
creased renal nucleic acid synthesis and renal cell mitosis [1—3].
Increased immediate early gene expression precedes these
events and their immediate but short-term expression is very
similar to that observed when cells enter the growth cycle after
stimulation by serum or specific growth factors [3]. Thus it
seems likely that the expression of the immediate early genes by
the kidney after renal ischemia is related to the process of cell
growth and division. By contrast, renal ischemia and cisplatin-
induced renal failure reduce the expression of two prominently
expressed genes in the kidney, prepro-epidermal growth factor
(preproEGF) and Tamm-Horsfall [3—5] and unpublished obser-
vations). While the reduced expression of these genes occurs
before the increase in DNA synthesis, reduced expression
remains low throughout and beyond the period of active DNA
synthesis.
To date, this decline in renal preproEGF and TH expression
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BUO. Rats undergoing obstructive renal failure reduce food
intake and lose weight. For this reason our studies were
performed under conditions of paired feeding to prevent any
differences in renal mRNA measurements secondary to differ-
ences in food intake. All experiments were performed in
Sprague-Dawley rats weighing 250 to 500 g, housed in metal
metabolic cages fitted with fine mesh screens. Each animal was
offered 30 grams of a standard rat chow (Rat Chow 5012,
Ralston Purina Co., St. Louis, Missouri, USA, containing
22.8% protein, 4.5% fat, 4.6% fiber and water) and 50 ml of tap
water daily. After a period of four to six days, when they ate
their allotted portions of food, rats were anesthetized (ket-
amine, 75 mg/kg) and, under sterile conditions, both ureters
occluded with metal removable surgiclips (5 mm) placed around
each ureter with its surrounding connective tissue and fat. The
period of BUO varied up to 24 hours in duration and only rats
who were totally anuric during the period of BUO were studied.
Animals were sacrificed after varying periods of BUO without
release, or reoperated on 24 hours later to remove the clips for
studies after relief of obstruction.
UUO. Animals treated as above underwent unilateral ure-
teral obstruction (UUO) and were sacrificed either after 24
hours without relief of obstruction or at varying times after
relief of 24 hours UUO.
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Control. Animals underwent sham operations and were pair
fed to control for changes induced by surgery and food intake.
In sham operated animals, anesthesia, manipulation of the renal
hila, and exposure of the peritoneal cavity was performed as in
the obstructive studies, but obstruction of the ureters was
omitted.
The daily consumption of food and water was measured and
urine was collected under oil in plastic cylinders to which
thymol was added. Each day the rats were weighed and the
24-hour urine volume measured. A portion of the urine was
frozen and stored at —20°C for later analysis of osmolality and
EGF concentration. Blood was taken by cardiac puncture
under anesthesia at varying time periods of BUO or UUO and
one to six days after relief of BUO. Animals were sacrificed at
similar intervals as required by the specific protocols.
RNA blot analysis
Relative levels of mRNA were analyzed by Northern analysis
in at least two animals for each condition studied. Total cortical
and outer medullary RNA was isolated from anesthetized
animals at varying time periods after obstruction and release or
sham treatment by the guanidinium thiocyanate procedure [7]
after intraarterial perfusion of the kidney with cold buffered
saline (154 mri NaC1, 50 mr'i Tris, pH 7.4). Poly(A) RNA was
isolated by oligo(dT)-cellulose (Type 3. Collaborative Re-
search, Bedford, Massachusetts, USA) chromatography [81.
Poly(A) RNA (5 jxg/lane) was either electrophoresed through
formaldehyde-1% agarose gels [91 and transferred overnight to
nitrocellulose membranes (BA 85, Schleicher and Schuell, Inc.,
Keene, New Hampshire, USA) as described [101, or applied
directly (1 p.gllane) to the membranes by filtration. Hybridiza-
tion was carried out with nick translated DNAs labeled with
32P-dCTP (500 Ci/mmol) to a specific activity of approximately
5 x 10 cpm/jxg DNA [11]. Nitrocellulose blots were prehybrid-
ized at 45°C overnight with denatured salmon sperm DNA (0.1
mg/ml) in 5 x SSC, 50% deionized formamide, and 0.02%
Denhardt's solution (0.02% ficoll, 0.02% polyvinylpyrrolidine,
and 0.02% BSA) and hybridized at 45°C overnight in the same
solution containing 10% dextran sulfate and radiolabeled probe.
Non-specifically bound radioactivity was removed by extensive
washing as described [12]. After washing, the blots were air
dried and exposed overnight to Kodak XAR film at —70° with
intensifying screens. Quantitative variabilities of isolation and
transfer of RNAs were accounted for by reprobing the Northern
blots with a eDNA probe for glyceraldehyde-3-phosphate-
dehydrogenase. The sequences used for nick translation were
excised with appropriate restriction endonucleases and purified
by preparative gel electrophoresis. The cDNAs for murine
preproEGF (a 700 bp Pst I fragment of pmegfl0, a gift of G. Bell
[13]); TH (a 2.2 kb TH Eco Rl fragment in pBR322, a gift of
D.V. Goeddel [14]; and rat glyceraldehyde-3-phosphate-dehy-
drogenase from prGAPDH-13, a gilt of J.M. Blanchard [15]). To
quantify levels of preproEGF mRNA, autoradiograms were
scanned in two dimensions using an Apple scanner and densi-
tometry employing 256 gray scales on an Apple Macintosh hex
computer using Image 1.36 software (Wayne Rasband, National
Institutes of Health).
3H-thy,nidine incorporation
Studies were performed in 10 BUO and six sham operated
rats after 24 hours of obstruction. One hour after i.p. 3H-methyl
thymidine (0.5 p.Ci/g body wt), animals were anesthetized, the
kidneys flushed with 0.9% NaC1 intraarterially, and removed.
Portions of the entire kidney were homogenized in 40 volumes
of 150 mtvi NaCI, 100 mM EDTA pH 8. SDS was added to a final
concentration of 1% and mixed gently. NaC1O4 was added to a
final concentration of 1 M. The mixture was extracted 1:1 with
phenol:isoamyl alcohol:chloroform (1:1:24) and spun at 5000
rpm for 10 minutes. Ninety-five percent ethanol was then added
to the supernatant and with gentle stirring the precipitated DNA
removed with a glass rod. After washing with 75% ethanol, the
precipitate was dissolved in 100 msi NaCI, 50 msi Tris, pH 7.5,
5 mM EDTA (STE) at 37°C and treated with DNase free RNase
A (20 gIml) for one hour at 37°C. The DNA was reprecipitated
and suspended in STE and stored at 4°C for further analysis.
Analytical methods
Urine samples were assayed for EGF receptor-binding activ-
ity in duplicate using membranes from A431 cells as the source
of receptors and highly purified mouse EGF as 1251-labeled
tracer and reference standard (Biomedical Technologies,
Stoughton, Massachusetts, USA). A standard curve using
known concentrations of unlabeled mouse epidermal growth
factor reference standard was included in each assay. Blood
urea nitrogen was measured using the diacetyl monoxime
method [16]. 3H activity in urine, plasma, tubule fluid and
isolated DNA was determined in a liquid scintillation spectrom-
eter (Packard Tri-Carb model 2425, Downers Grove, Illinois,
USA). The concentration of DNA was determined by measur-
ing its absorbance at 260 xm.
Results
The effect of bilateral ureteral obstruction on blood urea
nitrogen is shown in Figure 1. The BUN rises progressively
through 24 hours of BUO to a peak value of 123.3 14.1 mg%.
Following release BUN falls to 38.5 5.4 mg% at 24 hours and
to near control values by four days post-release. Thus 24 hours
of BUO and release is a partially reversible form of acute renal
failure.
The results of the studies of renal DNA 3H-thymidine incor-
poration are summarized in Figure 2. DNA synthesis was not
increased by bilateral ureteral obstruction of 24 hours duration
when BUN values had peaked. Similar measurements during
renal ischemia, by contrast, reveal increases in values of
3H-thymidine incorporation that reach a peak that coincides
with maximal BUN values [3]. This difference cannot be
explained by differences in kidney content of 3H-thymidine
(unpublished observations).
Northern analysis of kidney mRNA are summarized in Figure
3. Renal preproEGF (panel A) and TH mRNAs decreased
beginning at four hours of BUO and were not detectable after 12
hours of BUO. PreproEGF and TH mRNAs were also mark-
edly reduced after 24 hours of UUO. In studies of the long term
effects of BUO (Fig. 4), Northern blot analysis revealed that
although 24 hours of BUO reduced renal preproEGF expression
to virtually undetectable levels these levels increased progres-
sively when the ureteral clamp was removed. Dot blot analysis
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Daily urinary excretion of EGF was measured at varying
times after the release of 24 hours BUO and the results are
summarized in Figure 6. Urinary EGF excretion fell from mean
values of 13.5 1.1 pg/day before ureteral obstruction to 0,9
0.2 pg/day during the first 24 hours after release of the ureteral
clamp. Daily EGF excretion increased progressively but to only
8.8 2.0 p,g/day by the fourth day after release, and signifi-
cantly below the control levels.
Additional studies were performed to determine the response
of renal preproEGF and TH expression to UUO and subse-
quent release. Figure 7 summarizes the results of Northern
analysis of renal preproEGF and GAPDH mRNA and shows
marked reduction of preproEGF mRNA after 24 hours of UUO
and a gradual return of preproEGF mRNA to 58.4 13.8% (N
= 3) of control values four days after release of 24 hours of
(4) UUO. Similarly, Northern analysis of TH mRNA (Fig. 8)
(2) (2) (3) shows that TH mRNA falls markedly after UUO and returnsI I I I I I toward normal by four days after release of UUO (82.5 9.8%
12 24 1 2 3 versus control, N = 2).
Discussion
We have previously established the interrelationship between
acute renal failure and decreased preproEGF and TH mRNA
synthesis [3, 5]. These models of ARF were coincident with
renal cell necrosis and regeneration. We wished to investigate
whether the decrease in mRNA levels was dependent on either
cell necrosis or the commitment to increased DNA synthesis.
The results of the present studies demonstrate that renal cell
necrosis is not a necessary precondition for reduced renal
expression of preproEGF and Tamm-Horsfall. Neither en-
hanced renal DNA synthesis nor prominent expression of the
immediate early genes were demonstrated after bilateral ure-
teral obstruction, yet renal mRNA for preproEGF and TH fell
markedly. The results of the present studies would suggest that
the decline in preproEGF mRNA is not sufficient by itself to
signal enhanced renal DNA synthesis.
The decline in expression was related to the length of ureteral
obstruction. PreproEGF and TH mRNA declined initially at
four hours of obstruction and were undetectable at 12 hours of
obstruction, This time course is quite similar to the decline in
preproEGF and TH mRNA after release of 50 minutes of renal
hilar clamping. As in ischemia, the return of renal EGF produc-
tion is slow, as renal preproEGF mRNA and EGF excretion are
well below pre-obstruction control values four days after re-
lease (Figs. 4 and 5). Also, and similar to renal ischemia, the
decline in preproEGF and TH mRNA was the same whether
ureteral obstruction was unilateral or bilateral, eliminating a
prominent role for uremia in the decline in renal EGF produc-
tion. Taken together these data are consistent with the notion
that ureteral obstruction reduces preproEGF and TH expres-
sion by a direct effect of obstructing the ureters.
Previous studies show that ureteral obstruction has diverse
effects on thick ascending limb and distal tubule, the sites of
synthesis of both preproEGF and TH [17, 18]. Ureteral obstruc-
tion increases intraluminal pressure [19], reduces transepithelial
NaCl transport [201 and Na-K ATPase levels [211 in the thick
ascending limb. On the other hand, ureteral obstruction in-
creases thick ascending limb H-ATPase activity [21]. Thus
obstruction causes both positive and negative effects on thick
ascending limb synthetic and metabolic function. The present
z
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Fig. 2. Renal DNA synthesis in sham treated animals and in animals
24 hours after bilateral ureteral obstruction. The numbers within the
bars indicate the number of animals studied.
of kidney mRNA using the Tamm-Horsfall cDNA (Fig. 5)
shows a similar progressive increase in Tamm-Horsfall mRNA
with release of the ureteral obstruction. By contrast, sham
operation itself did not effect renal preproEGF or TH expres-
sion as mRNA levels for each showed the same proportion of
GAPDH mRNA [preproEGF 88 0.3%, N = 4 (unoperated)
and 108 23%, N = 8 (sham operated), NS; TH 60 19%, N
= 5 (unoperated) and 60 12%, N = 5 (sham operated), NS].
-
o
 
CD
 V 1 0 m
 C -n to
 
t0
 
U,
 I I I 
Is
 
I, 
Co
nt
ro
l 
N
o 
re
le
as
e 
N
) 
2 
da
y 
re
le
as
e 
a
 
3 
da
y r
e
le
as
e 
4 
da
y r
e
le
as
e 
5 
da
y 
re
le
as
e 
w
 
C C O
N)
 a o
f 
cm
 
-
v C I 
4 C) > -o C I 
-
o
 
CD
 V 0 m
 
C)
 
m
 
92 Storch et a!: Gene expression after ureteral obstruction
Fig. 3. A. Northern analysis of renal
preproEGF and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA at varying
times after unilateral (UUO) or bilateral
(BUO) ureteral obstruction. Five micrograms
of poly(A) RNA per lane. B. The blot from
panel A was reprobed with a Tamm-Horsfall
(TH) eDNA.
Fig. 4. Northern analysis of renal preproEGF
and GAPDH mRNA in control (lane 1) and in
animals with 24 hours of BUO without release
(lane 2); and in animals 2 days (lane 3); 3
days (lane 4); 4 days (lane 5); and 5 days
(lane 6) after release of 24 hours BUO. The
migration of 18s and 28s RNA is indicated on
the left.
studies further demonstrate that some of these effects of ob- bular pressure occur in either the ischemic or obstructive forms
struction on the thick ascending limb occur at the level of gene of acute renal failure and suggest that these functional changes
expression. may somehow play a role in the reduction in preproEGF and
The molecular mechanism of reduced expression was not TH expression. Ureteral obstruction has marked effects on
explored and whether ureteral obstruction reduces preproEGF three prominent intrarenal hormone systems: the metabolism of
and TH mRNA transcription or reduces mRNA stability will arachidonic acid, the renin-angiotensin system, and the renal
have to be determined. Reduced glomerular filtration rate and kallikrein-kinen system [22],so that interactions between these
thick ascending limb salt transport, as well as increased intratu- systems and EGF are possible. As bilateral ureteral obstruction
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Fig. 6. Daily urinary EGF excretion before (Pre) and after release of24hours BUD. < 0.001 compared to Pre-value; **p < 0.025; <
0.05, paired t-test. Control urinary EGF excretion was not different
from the PRE values and did not change significantly after surgery (data
not shown).
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Fig. 8. Northern analysis of renal TH and GAPDH mRNA in control
animals (lane 1) and in animals with 24 hours of UUO without release
and in animals at varying times after release of 24 hours of UUO.
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Fig. 5. Dot-blot analysis of TH and GAPDH
mRNA (1 ,ugllane) from male Sprague-Dawley
rat kidneys 24 hours after sham-operation
(lane 1), 24 hours after BUD (lane 2), and one
(lane 3), two (lane 4), three (lane 5), four
(lane 6), and five days (lane 7) after relief of
obstruction. Individual blots were hybridized
with probes specific for Tamm-Horsfall (A), or
GAPDH (B).
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increases systemic ANF levels but unilateral ureteral obstruc-
tion does not [231, interaction between ANF and EGF seems
unlikely. Additional studies will be necessary to pinpoint the
level at which obstruction affects the renal expression of
preproEGF and TH.
The possible role of reduced renal production of EGF and TH
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in the abnormal function of the kidney during obstruction is of
course unknown. It is interesting to note that both preproEGF
and TH increase post-natally [18, 241 so that interruption of this
pattern of expression could in part be responsible for the severe
consequences of prolonged ureteral obstruction on renal func-
tion and morphology, especially in the neonatal period [25].
Cloning of the rat preproEGF gene [26] should provide an
important opportunity to determine the mechanism by which
obstruction affects renal gene expression.
Reprint requests to Robert Safirstein, M.D., Mount Sinai School of
Medicine, I Gustave L. Levy Place, New York, New York 10029, USA.
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